BSE 2030.55 NSE 2030.00
  • Pegfilgrastim approval in Canada, Mexico and Thailand
  • Pegfilgrastim filing across the globe
  • Global Phase 3 started for Denosumab & Aflibercept
  • Joint venture with I’rom for Denosumab in Japan